The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.
M Stoll;U M Steckelings;M Paul;S P Bottari.
Journal of Clinical Investigation (1995)
Angiotensin Type 1 Receptor Blockers Induce Peroxisome Proliferator–Activated Receptor-γ Activity
Michael Schupp;Jürgen Janke;Ronald Clasen;Thomas Unger.
Quantitative real-time RT-PCR data analysis: current concepts and the novel “gene expression’s CT difference” formula
Jan H. Schefe;Kerstin E. Lehmann;Ivo R. Buschmann;Thomas Unger.
Journal of Molecular Medicine (2006)
Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection.
Duska Dragun;Dominik N. Müller;Jan Hinrich Bräsen;Lutz Fritsche.
The New England Journal of Medicine (2005)
Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
W Linz;G Wiemer;P Gohlke;T Unger.
Pharmacological Reviews (1995)
2020 International Society of Hypertension global hypertension practice guidelines.
Thomas Unger;Claudio Borghi;Fadi Charchar;Nadia A Khan.
Journal of Hypertension (2020)
T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance.
Ulrich Kintscher;Martin Hartge;Katharina Hess;Anna Foryst-Ludwig.
Arteriosclerosis, Thrombosis, and Vascular Biology (2008)
The role of the renin-angiotensin system in the development of cardiovascular disease.
American Journal of Cardiology (2002)
Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats.
Eugene C. Fletcher;Joachim Lesske;Wei Qian;Charles C. Miller.
Angiotensin AT1/AT2 receptors: regulation, signalling and function.
Elena Kaschina;Thomas Unger.
Blood Pressure (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: